North America Immunoglobulin Market Forecast 2022-2030
Description
North America Immunoglobulin Market Forecast 2022-2030
KEY FINDINGS
The North America immunoglobulin market is predicted to record a CAGR of 6.95% during the forecasted period of 2022 to 2030. The market growth of the region is propelled by major factors such as the high incidence of various diseases, the presence of key industry players, and the growth in product approvals by the United States Food and Drug Administration (FDA).
MARKET INSIGHTS
The North America immunoglobulin market growth assessment covers the evaluation of Canada and the United States. In Canada, intravenous immunoglobulin is primarily distributed by the Canadian Blood System to the country’s blood banks within hospital settings. Subsequently, hospital blood banks then dispense intravenous immunoglobulin to individual patients as prescribed. In addition, various institutions also maintain a comprehensive database inventory regarding the usage of the same. Intravenous immunoglobulin is licensed by Health Canada for the treatment of secondary and primary immune deficiencies, allogeneic bone marrow transplantation, idiopathic thrombocytopenic purpura, Kawasaki disease, chronic B-cell lymphocytic leukemia, as well as pediatric HIV-infection.
Over recent years, Canada has also recorded significant infrastructural development associated with immunoglobulin and plasma. This factor is set to have a positive impact on the country’s market growth. Aligning with this, in 2019, Canadian Blood Services announced its proposition to open plasma donation sites across three provinces in order to secure the supply for patients. As a result, these factors are expected to supplement the growth of the immunoglobulin market in North America during the forecast period.
COMPETITIVE INSIGHTS
Top players operating in the market include ADMA Biologics, Pfizer Inc, CSL Behring, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
KEY FINDINGS
The North America immunoglobulin market is predicted to record a CAGR of 6.95% during the forecasted period of 2022 to 2030. The market growth of the region is propelled by major factors such as the high incidence of various diseases, the presence of key industry players, and the growth in product approvals by the United States Food and Drug Administration (FDA).
MARKET INSIGHTS
The North America immunoglobulin market growth assessment covers the evaluation of Canada and the United States. In Canada, intravenous immunoglobulin is primarily distributed by the Canadian Blood System to the country’s blood banks within hospital settings. Subsequently, hospital blood banks then dispense intravenous immunoglobulin to individual patients as prescribed. In addition, various institutions also maintain a comprehensive database inventory regarding the usage of the same. Intravenous immunoglobulin is licensed by Health Canada for the treatment of secondary and primary immune deficiencies, allogeneic bone marrow transplantation, idiopathic thrombocytopenic purpura, Kawasaki disease, chronic B-cell lymphocytic leukemia, as well as pediatric HIV-infection.
Over recent years, Canada has also recorded significant infrastructural development associated with immunoglobulin and plasma. This factor is set to have a positive impact on the country’s market growth. Aligning with this, in 2019, Canadian Blood Services announced its proposition to open plasma donation sites across three provinces in order to secure the supply for patients. As a result, these factors are expected to supplement the growth of the immunoglobulin market in North America during the forecast period.
COMPETITIVE INSIGHTS
Top players operating in the market include ADMA Biologics, Pfizer Inc, CSL Behring, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Table of Contents
164 Pages
- 1. Research Scope & Methodology
- 1.1. Study Objectives
- 1.2. Scope Of Study
- 1.3. Methodology
- 1.4. Assumptions & Limitations
- 2. Executive Summary
- 2.1. Market Size & Estimates
- 2.2. Market Overview
- 3. Market Dynamics
- 3.1. Key Drivers
- 3.1.1. Growth In Geriatric Population
- 3.1.2. Prevalence Of Immunodeficiency Diseases And Autoimmune Disorders
- 3.1.3. Increasing Research And Development Activities
- 3.2. Key Restraints
- 3.2.1. High Cost Of Therapy
- 3.2.2. High Risk Of Side Effects
- 4. Key Analytics
- 4.1. Impact Of Covid-19 On Immunoglobulin Market
- 4.2. Key Market Trends
- 4.3. Porter’s Five Forces Analysis
- 4.3.1. Buyers Power
- 4.3.2. Suppliers Power
- 4.3.3. Substitution
- 4.3.4. New Entrants
- 4.3.5. Industry Rivalry
- 4.4. Opportunity Matrix
- 4.5. Vendor Landscape
- 4.6. Key Buying Criteria
- 4.6.1. Source
- 4.6.2. Application
- 4.6.3. Epitope
- 4.6.4. Validation
- 4.7. Regulatory Framework
- 5. Market By Product
- 5.1. Igg
- 5.2. Iga
- 5.3. Igm
- 5.4. Ige
- 5.5. Igd
- 6. Market By Mode Of Delivery
- 6.1. Intravenous Immunoglobulin
- 6.2. Subcutaneous Immunoglobulin
- 6.3. Intramuscular Immunoglobulin
- 7. Market By Application
- 7.1. Hypogamma Globulinemia
- 7.2. Chronic Inflammatory Demyelinating Polyneuropathy
- 7.3. Primary Immunodeficiency Diseases
- 7.4. Myasthenia Gravis
- 7.5. Multifocal Motor Neuropathy
- 7.6. Idiopathic Thrombocytopenic Purpura (Itp)
- 7.7. Inflammatory Myopathies
- 7.8. Specific Antibody Deficiency
- 7.9. Guillain-barre Syndrome
- 7.10. Other Applications
- 8. Market By Distribution Channel
- 8.1. Hospital Pharmacy
- 8.2. Specialty Pharmacy
- 8.3. Other Distribution Channels
- 9. Market By End-user
- 9.1. Hospitals & Clinics
- 9.2. Homecare
- 10. Geographical Analysis
- 10.1. North America
- 10.1.1. Market Size & Estimates
- 10.1.2. Key Growth Enablers
- 10.1.3. Key Challenges
- 10.1.4. Key Players
- 10.1.5. Country Analysis
- 10.1.5.1. United States
- 10.1.5.2. Canada
- 11. Competitive Landscape
- 11.1. Key Strategic Developments
- 11.1.1. Mergers & Acquisitions
- 11.1.2. Product Launches & Developments
- 11.1.3. Partnerships & Agreements
- 11.1.4. Business Expansions & Divestitures
- 11.2. Company Profiles
- 11.2.1. Adma Biologics
- 11.2.2. Bio Products Laboratory
- 11.2.3. Biotest Ag
- 11.2.4. China Biologic Products Inc
- 11.2.5. Csl Behring
- 11.2.6. Grifols Sa
- 11.2.7. Kamada Ltd
- 11.2.8. Kedrion Biopharma
- 11.2.9. Lfb Group
- 11.2.10. Octapharma Ag
- 11.2.11. Pfizer Inc
- 11.2.12. Sanquin Plasma Products Bv
- 11.2.13. Shanghai Raas Blood Products Co Ltd
- 11.2.14. Sichuan Yuanda Shuyang Pharmaceutical Co Ltd
- 11.2.15. Takeda Pharmaceutical Company Limited
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
